<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Proc Natl Acad Sci U S A</journal-id>
<journal-id journal-id-type="iso-abbrev">Proc. Natl. Acad. Sci. U.S.A</journal-id>
<journal-id journal-id-type="hwp">pnas</journal-id>
<journal-id journal-id-type="pmc">pnas</journal-id>
<journal-id journal-id-type="publisher-id">PNAS</journal-id>
<journal-title-group>
<journal-title>Proceedings of the National Academy of Sciences of the United States of America</journal-title>
</journal-title-group>
<issn pub-type="ppub">0027-8424</issn>
<issn pub-type="epub">1091-6490</issn>
<publisher>
<publisher-name>National Academy of Sciences</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28696314</article-id>
<article-id pub-id-type="pmc">5544257</article-id>
<article-id pub-id-type="publisher-id">201615719</article-id>
<article-id pub-id-type="doi">10.1073/pnas.1615719114</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>PNAS Plus</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Biological Sciences</subject>
<subj-group>
<subject>Medical Sciences</subject>
</subj-group>
</subj-group>
<series-title>PNAS Plus</series-title>
</article-categories>
<title-group>
<article-title>Loss-of-function mutation in <italic>Mirta22/Emc10</italic> rescues specific schizophrenia-related phenotypes in a mouse model of the 22q11.2 deletion</article-title>
<alt-title alt-title-type="short"><italic>Mirta22</italic> rescues selective deficits in a SCZ model</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Diamantopoulou</surname>
<given-names>Anastasia</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sun</surname>
<given-names>Ziyi</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mukai</surname>
<given-names>Jun</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xu</surname>
<given-names>Bin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fenelon</surname>
<given-names>Karine</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
<xref ref-type="author-notes" rid="fn1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Karayiorgou</surname>
<given-names>Maria</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="corresp" rid="cor1">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn2">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gogos</surname>
<given-names>Joseph A.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
<xref ref-type="corresp" rid="cor1">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn2">
<sup>3</sup>
</xref>
</contrib>
<aff id="aff1"><sup>a</sup>Department of Psychiatry, College of Physicians and Surgeons, <institution>Columbia University</institution>, New York, <addr-line>NY</addr-line> 10032;</aff>
<aff id="aff2"><sup>b</sup>Department of Physiology and Cellular Biophysics, College of Physicians and Surgeons, <institution>Columbia University</institution>, New York, <addr-line>NY</addr-line> 10032;</aff>
<aff id="aff3"><sup>c</sup>Department of Neuroscience, College of Physicians and Surgeons, <institution>Columbia University</institution>, New York, <addr-line>NY</addr-line> 10032</aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><sup>2</sup>To whom correspondence may be addressed. Email: <email>mk2758@cumc.columbia.edu</email> or <email>jag90@columbia.edu</email>.</corresp>
<fn fn-type="edited-by">
<p>Edited by Stephen T. Warren, Emory University School of Medicine, Atlanta, GA, and approved May 5, 2017 (received for review September 20, 2016)</p>
</fn>
<fn fn-type="con">
<p>Author contributions: A.D., Z.S., J.M., B.X., K.F., M.K., and J.A.G. designed research; A.D., Z.S., J.M., B.X., and K.F. performed research; A.D., Z.S., J.M., B.X., and K.F. analyzed data; J.A.G. supervised the work; and A.D. and J.A.G. wrote the paper.</p>
</fn>
<fn fn-type="present-address" id="fn1">
<p><sup>1</sup>Present address: Department of Biological Sciences, University of Texas at El Paso, El Paso, TX 79968.</p>
</fn>
<fn fn-type="equal" id="fn2">
<p><sup>3</sup>M.K. and J.A.G. share senior authorship.</p>
</fn>
<fn fn-type="COI-statement">
<p>The authors declare no conflict of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>25</day>
<month>7</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>10</day>
<month>7</month>
<year>2017</year>
</pub-date>
<volume>114</volume>
<issue>30</issue>
<fpage>E6127</fpage>
<lpage>E6136</lpage>
<permissions></permissions>
<self-uri xlink:href="pnas.201615719.pdf" xlink:title="pdf"></self-uri>
<abstract abstract-type="executive-summary">
<title>Significance</title>
<p>Despite substantial progress in the field of schizophrenia (SCZ) genetics, the heterogeneity of genetic etiology and neural complexity has rendered the task of developing improved treatments inauspicious. Thus, there is need to identify convergent neural substrates and underlying molecular mechanisms that can serve the prevention or reversal of disease progression. Our extensive characterization of an animal model of the 22q11.2 deletion, one of the strongest genetic risk factors for SCZ, when combined with a loss-of-function (LoF) mutation for a microRNA-dependent upregulated target, offers a proof of principle for such approaches. Hence, identification of variants that confer protection against disease by disabling protein function via LoF effects holds great promise for devising therapeutic schemes to restore or prevent disease symptoms.</p>
</abstract>
<abstract>
<p>Identification of protective loss-of-function (LoF) mutations holds great promise for devising novel therapeutic interventions, although it faces challenges due to the scarcity of protective LoF alleles in the human genome. Exploiting the detailed mechanistic characterization of animal models of validated disease mutations offers an alternative. Here, we provide insights into protective-variant biology based on our characterization of a model of the 22q11.2 deletion, a strong genetic risk factor for schizophrenia (SCZ). Postnatal brain up-regulation of <italic>Mirta22/Emc10</italic>, an inhibitor of neuronal maturation, represents the major transcriptional effect of the 22q11.2-associated microRNA dysregulation. Here, we demonstrate that mice in which the <italic>Df(16)A</italic> deficiency is combined with a LoF <italic>Mirta22</italic> allele show rescue of key SCZ-related deficits, namely prepulse inhibition decrease, working memory impairment, and social memory deficits, as well as synaptic and structural plasticity abnormalities in the prefrontal cortex. Additional analysis of homozygous <italic>Mirta22</italic> knockout mice, in which no alteration is observed in the above-mentioned SCZ-related phenotypes, highlights the deleterious effects of <italic>Mirta22</italic> up-regulation. Our results support a causal link between dysregulation of a miRNA target and SCZ-related deficits and provide key insights into beneficial LoF mutations and potential new treatments.</p>
</abstract>
<kwd-group>
<kwd>LoF mutations</kwd>
<kwd>22q11.2 microdeletion</kwd>
<kwd>Mirta22/Emc10</kwd>
</kwd-group>
<funding-group>
<award-group id="gs1">
<funding-source id="sp1">HHS | NIH | National Institute of Mental Health (NIMH)<named-content content-type="funder-id">100000025</named-content></funding-source>
<award-id rid="sp1">MH097879</award-id>
</award-group>
<award-group id="gs2">
<funding-source id="sp2">HHS | NIH | National Institute of Mental Health (NIMH)<named-content content-type="funder-id">100000025</named-content></funding-source>
<award-id rid="sp2">MH097879</award-id>
</award-group>
<award-group id="gs3">
<funding-source id="sp3">HHS | NIH | National Institute of Mental Health (NIMH)<named-content content-type="funder-id">100000025</named-content></funding-source>
<award-id rid="sp3">MH097879</award-id>
</award-group>
<award-group id="gs4">
<funding-source id="sp4">HHS | NIH | National Institute of Mental Health (NIMH)<named-content content-type="funder-id">100000025</named-content></funding-source>
<award-id rid="sp4">MH097879</award-id>
</award-group>
<award-group id="gs5">
<funding-source id="sp5">HHS | NIH | National Institute of Mental Health (NIMH)<named-content content-type="funder-id">100000025</named-content></funding-source>
<award-id rid="sp5">MH097879</award-id>
</award-group>
<award-group id="gs6">
<funding-source id="sp6">HHS | NIH | National Institute of Mental Health (NIMH)<named-content content-type="funder-id">100000025</named-content></funding-source>
<award-id rid="sp6">MH097879</award-id>
</award-group>
<award-group id="gs7">
<funding-source id="sp7">HHS | NIH | National Institute of Mental Health (NIMH)<named-content content-type="funder-id">100000025</named-content></funding-source>
<award-id rid="sp7">MH097879</award-id>
</award-group>
</funding-group>
<counts>
<page-count count="10"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>